1 completed. .
Follow MET + SGLT2i: new trials by email Literature Review of MET + SGLT2i trials Research Report on MET + SGLT2i
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antidiabetic Medications and Risk of Cancer Metformin, sulphonylurea, DPP-4 inhibitor - Cancer | Completed | University of Pecs | 74799 | 2025-03-15 | 2026-06-05 |
Diabetes Mellitus, Type 2 (1) · Neoplasms (1)
Hungary (1)